Fever with Rash: Life-Threatening Causes, ER Approach & Management

⚠️ The Critical Principle

Part 1: Classify by Rash Morphology

Part 2: The Life-Threatening Diagnoses in Detail

1. Meningococcemia / Purpura Fulminans

• Immediate penicillin G or ceftriaxone 2g IV — do NOT delay for LP if meningitis suspected
• Blood cultures × 2 before antibiotics if possible, but never delay treatment
• Aggressive IV fluid resuscitation; vasopressors (norepinephrine) for refractory shock
• ICU admission; treat DIC (FFP, platelets)
• Dexamethasone 0.15 mg/kg q6h IV for suspected bacterial meningitis (before or with first antibiotic dose)
• Droplet precautions; prophylaxis for close contacts (rifampicin, ciprofloxacin, or ceftriaxone)

2. Rocky Mountain Spotted Fever (RMSF)

• Doxycycline 100 mg IV/PO q12h — first-line in ALL ages (including children). Delay dramatically increases mortality.
• Chloramphenicol is an alternative only for severe tetracycline allergy (not preferred, especially in children <9 yr anymore — doxycycline is now recommended for all)
• Avoid: sulfa drugs (exacerbate illness); Rickettsia is resistant to penicillins, cephalosporins, aminoglycosides, erythromycin
• Ehrlichiosis is clinically similar and also treated with doxycycline

3. Toxic Shock Syndrome (TSS)

1. Fever ≥38.9°C
2. Diffuse macular erythroderma
3. Desquamation 1–2 weeks later
4. Hypotension (SBP ≤90 mmHg)
5. Multisystem involvement (≥3 organ systems): GI, muscular, mucous membranes, renal, hepatic, hematologic (platelets <100,000), CNS

• Remove the source (remove tampon, drain abscess, debride wound)
• Aggressive IV fluid resuscitation; vasopressors for shock
• Empirical antibiotics covering MRSA and S. pyogenes:
  • Vancomycin + clindamycin (clindamycin reduces toxin production via ribosomal inhibition — a key adjunct)
  • Alternatives: linezolid, piperacillin-tazobactam, meropenem
• IVIG 1–2 g/kg single dose in refractory shock (neutralizes superantigens) — considered in severe/refractory cases
• ICU admission, ventilatory support as needed

4. Stevens-Johnson Syndrome (SJS) / Toxic Epidermal Necrolysis (TEN)

• Stop the causative drug immediately — this is the single most important intervention
• Transfer to burn unit or ICU
• Wound care (non-adherent dressings), fluid/electrolyte replacement
• Ophthalmology consult (prevent ocular sequelae)
• Do NOT use systemic corticosteroids (controversial; may increase mortality)
• Cyclosporine, IVIG, or anti-TNF agents (etanercept, infliximab) used in severe cases
• SCORTEN score guides prognosis and ICU triage

5. Necrotizing Fasciitis

• Emergent surgical consultation for immediate wide debridement — this is the key intervention
• Broad-spectrum IV antibiotics: piperacillin-tazobactam + clindamycin + vancomycin
• ICU admission, resuscitation

6. Disseminated Gonococcemia / Endocarditis with Septic Emboli

Part 3: ER Approach Algorithm

FEVER + RASH → Acutely ill? → YES → TREAT AS EMERGENCY

Step 1: RAPID ASSESSMENT (< 5 min)
  ├─ Airway, breathing, circulation, mental status
  ├─ IV access × 2 + monitoring + O₂
  └─ Is patient in SHOCK? → Start resuscitation simultaneously

Step 2: RASH CHARACTERIZATION (Bedside)
  ├─ Petechial/purpuric/non-blanching?
  │    → Meningococcemia, RMSF, DIC, endocarditis
  │    → Draw blood cultures, give ceftriaxone NOW
  ├─ Diffuse erythroderma + mucous membrane involvement?
  │    → TSS: remove source, vancomycin + clindamycin
  ├─ Blistering / skin detachment + mucosal lesions?
  │    → SJS/TEN: stop offending drug, dermatology/burns
  └─ Unilateral extremity pain, erythema, crepitus?
       → Necrotizing fasciitis: surgical consult STAT

Step 3: TARGETED HISTORY
  └─ Tick exposure? (RMSF/Ehrlichiosis)
  └─ Recent drugs? (SJS/TEN/DRESS)
  └─ Tampon/wound/postoperative? (TSS)
  └─ Sexual contacts? (Gonococcemia)
  └─ Travel? Immunosuppression? Animal exposures?

Step 4: INVESTIGATIONS (DO NOT DELAY TREATMENT)
  ├─ CBC, BMP, LFTs, coagulation (PT/PTT/fibrinogen/D-dimer)
  ├─ Blood cultures × 2–3
  ├─ Wound/mucosal cultures, throat swab
  ├─ LP if meningococcemia suspected (after CT if focal neuro signs)
  └─ Skin biopsy (if stable — Rickettsia immunofluorescence, SJS)

Step 5: EMPIRICAL TREATMENT (while awaiting results)
  └─ See table below

Part 4: Empirical Treatment Summary Table

The Non-Negotiable Rules in the ER

1. Petechial rash + fever = meningococcemia until proven otherwise — antibiotics before LP, before CT, before almost everything
2. RMSF: treat empirically with doxycycline — waiting for serology kills patients; "failure to administer antibiotics in a timely fashion dramatically increases morbidity and mortality" — Rosen's Emergency Medicine
3. SJS/TEN: stop the drug immediately — the most critical single action
4. TSS: source control first — antibiotic alone is insufficient without removing the infected focus
5. Necrotizing fasciitis: operate, not just observe — no amount of antibiotics replaces surgical debridement

Toxic Shock Syndrome — Pathophysiology

The Core Concept: Superantigen-Driven Immune Catastrophe

Step 1: Normal Antigen Presentation vs. Superantigen Action

1. Does not require processing by the APC
2. Binds outside the peptide-binding groove of MHC class II (to the α or β chain of MHC on the outer wall)
3. Simultaneously binds the Vβ region of the TCR β chain — a region shared by entire T-cell families, not the antigen-specific CDR3

Step 2: The Causative Toxins

Staphylococcal TSS

Streptococcal TSS

Strep TSS is actually more common than staph TSS: 2–4 cases vs 0.3–0.5 cases per 100,000 population respectively. Blood cultures are positive in >50% of strep TSS, versus only ~10% of staph TSS. — Fitzpatrick's Dermatology

Step 3: The Cytokine Storm

Superantigen + MHC class II (APC) + TCR Vβ (T cell)
        ↓
Massive polyclonal T-cell activation (5–20% of T-cell pool)
        ↓
Explosive release of:
  • IL-2 (T cells) → fever, T-cell proliferation
  • IFN-γ (T cells) → macrophage activation
  • TNF-α (macrophages) → fever, hypotension, shock
  • TNF-β / Lymphotoxin (T cells) → tissue damage
  • IL-1 (macrophages) → fever, endothelial damage
  • IL-6 (macrophages) → acute phase response, fever

• Mast cells release leukotrienes (vasoactive)
• Strep exotoxins potentiate endotoxin-induced shock and may suppress antibody synthesis

Step 4: From Cytokine Storm → Clinical Manifestations

CYTOKINE STORM (TNF-α, IL-1, IL-6, IFN-γ)
           │
           ├──→ ENDOTHELIAL INJURY
           │         ↓
           │    Capillary leak syndrome
           │    ↓                    ↓
           │  Tissue edema       Intravascular volume depletion
           │                          ↓
           │                     HYPOTENSION / SHOCK
           │
           ├──→ FEVER (IL-1, IL-6, TNF acting on hypothalamus)
           │
           ├──→ RASH (diffuse macular erythroderma)
           │    CLA+ T cells (skin-homing) traffic to skin → erythroderma
           │    Later: full-thickness desquamation (palms & soles, 1–2 wk)
           │
           ├──→ MULTIORGAN DYSFUNCTION
           │    • Renal: ischemia from hypoperfusion + direct cytokine injury
           │    • Hepatic: TNF-mediated hepatocyte injury
           │    • Hematologic: thrombocytopenia, DIC
           │    • CNS: altered consciousness (toxin + hypoperfusion)
           │    • Muscular: myositis (creatine kinase elevation)
           │
           └──→ MUCOUS MEMBRANE INFLAMMATION
                Strawberry tongue, conjunctivitis, vaginitis
                (direct cytokine effect + toxin crossing mucosal barriers)

Why skin homing?

Step 5: Staphylococcal vs. Streptococcal TSS — Key Pathophysiological Differences

Step 6: Why Clindamycin is Used (Mechanistic Basis)

Summary Diagram

  S. aureus / GAS
  (at mucosal surface, wound, soft tissue)
         ↓
  Toxin production (TSST-1 / SPEA / SPEB)
         ↓
  Superantigen bridges:
  MHC class II (APC) ←→ TCR Vβ (T cell)
  [BYPASSES normal antigen processing]
         ↓
  5–20% of T cells activated simultaneously
         ↓
  Cytokine storm: IL-2, TNF-α, TNF-β, IFN-γ, IL-1, IL-6
         ↓
  ┌──────────────────────────────────────────┐
  │  Capillary leak → hypovolemia → shock    │
  │  Endothelial damage → multiorgan failure │
  │  CLA+ T cells to skin → erythroderma    │
  │  Hypothalamic prostaglandins → fever     │
  │  Mucous membrane inflammation            │
  │  Desquamation at 1–2 weeks              │
  └──────────────────────────────────────────┘